ATE249841T1 - Immunogene zubereitungen - Google Patents

Immunogene zubereitungen

Info

Publication number
ATE249841T1
ATE249841T1 AT95936690T AT95936690T ATE249841T1 AT E249841 T1 ATE249841 T1 AT E249841T1 AT 95936690 T AT95936690 T AT 95936690T AT 95936690 T AT95936690 T AT 95936690T AT E249841 T1 ATE249841 T1 AT E249841T1
Authority
AT
Austria
Prior art keywords
immunogenic preparations
immunogenic composition
immunogenic
preparations
solubilised
Prior art date
Application number
AT95936690T
Other languages
English (en)
Inventor
Roger Randal Charles New
Gardens
Original Assignee
Vaxcine Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaxcine Ltd filed Critical Vaxcine Ltd
Application granted granted Critical
Publication of ATE249841T1 publication Critical patent/ATE249841T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95936690T 1994-11-15 1995-11-14 Immunogene zubereitungen ATE249841T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422990A GB9422990D0 (en) 1994-11-15 1994-11-15 Immunogenic compositions
PCT/GB1995/002675 WO1996014871A1 (en) 1994-11-15 1995-11-14 Immunogenic compositions

Publications (1)

Publication Number Publication Date
ATE249841T1 true ATE249841T1 (de) 2003-10-15

Family

ID=10764393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95936690T ATE249841T1 (de) 1994-11-15 1995-11-14 Immunogene zubereitungen

Country Status (19)

Country Link
EP (1) EP0792165B1 (de)
JP (1) JP4297515B2 (de)
KR (1) KR970706848A (de)
CN (1) CN100346828C (de)
AT (1) ATE249841T1 (de)
AU (1) AU700910B2 (de)
CA (1) CA2205083A1 (de)
DE (1) DE69531793T2 (de)
DK (1) DK0792165T3 (de)
ES (1) ES2210318T3 (de)
FI (1) FI972054A7 (de)
GB (1) GB9422990D0 (de)
IL (1) IL116010A0 (de)
MX (1) MX9703480A (de)
NO (1) NO972219L (de)
NZ (1) NZ295238A (de)
PT (1) PT792165E (de)
WO (1) WO1996014871A1 (de)
ZA (1) ZA959729B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
AU736038C (en) * 1997-07-10 2006-08-10 Intervet Australia Pty Limited Non-aqueous vaccines
WO1999002182A2 (en) * 1997-07-10 1999-01-21 Biotech Australia Pty. Limited Non-aqueous vaccines
CA2320041A1 (en) * 1998-02-12 1999-08-19 American Cyanamid Company Vaccines comprising interleukin-12 and herpes simplex viral antigen
AU2596699A (en) * 1998-02-12 1999-08-30 American Cyanamid Company Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
CN1200730C (zh) * 1998-02-12 2005-05-11 惠氏控股有限公司 用白细胞介素－12配制的肺炎球菌和脑膜炎球菌疫苗
US6630161B1 (en) * 1998-05-07 2003-10-07 Ribi Immunochem Research, Inc. Adjuvant composition and methods for its use
WO2000003724A1 (en) * 1998-07-16 2000-01-27 Hayashi, Akira Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
JP5731198B2 (ja) 2007-09-27 2015-06-10 イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． インビボでのポリヌクレオチドの送達のための連続疎水相を含む担体におけるリポソームの使用
JP5591705B2 (ja) * 2007-10-03 2014-09-17 イムノバクシーン・テクノロジーズ・インコーポレイテッド 抗原、両親媒性化合物及び疎水性担体を含有する組成物、並びにその使用
BRPI0913612B8 (pt) 2008-06-05 2021-05-25 Immunovaccine Technologies Inc composição injetável de vacina, método para obter a composição e uso da composição
CN103517714A (zh) * 2010-12-23 2014-01-15 英珀特疗法有限公司 用于刚地弓形虫感染和弓形体病的诊断和治疗的方法和蛋白抗原组合物
GB201107629D0 (en) 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
CN102277373B (zh) * 2011-08-15 2014-07-02 南京大学 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用
US10105435B2 (en) 2011-10-06 2018-10-23 Immunovaccine Technologies Inc. Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
DE69232940T2 (de) * 1991-06-26 2003-08-28 Yamanouchi Europe B.V., Leiderdorp Vesiculae in nichtpolaren Medien
AU7384994A (en) * 1993-08-06 1995-02-28 Opperbas Holding B.V. A method for high loading of vesicles with biopolymeric substances
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
DK0792165T3 (da) 2004-01-05
JPH10508834A (ja) 1998-09-02
CA2205083A1 (en) 1996-05-23
NO972219D0 (no) 1997-05-14
ZA959729B (en) 1997-05-15
FI972054L (fi) 1997-05-14
GB9422990D0 (en) 1995-01-04
EP0792165B1 (de) 2003-09-17
DE69531793T2 (de) 2004-07-15
CN1163575A (zh) 1997-10-29
EP0792165A1 (de) 1997-09-03
PT792165E (pt) 2004-02-27
FI972054A0 (fi) 1997-05-14
NO972219L (no) 1997-07-11
CN100346828C (zh) 2007-11-07
AU700910B2 (en) 1999-01-14
ES2210318T3 (es) 2004-07-01
NZ295238A (en) 1999-01-28
FI972054A7 (fi) 1997-05-14
DE69531793D1 (de) 2003-10-23
AU3853495A (en) 1996-06-06
IL116010A0 (en) 1996-01-31
JP4297515B2 (ja) 2009-07-15
KR970706848A (ko) 1997-12-01
MX9703480A (es) 1997-08-30
WO1996014871A1 (en) 1996-05-23

Similar Documents

Publication Publication Date Title
DK0792165T3 (da) Immunogene præparater
WO1997001640A3 (en) Vaccines against hepatitis c
NO20001768D0 (no) Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
ES2150493T3 (es) Adyuvantes para vacunas contra el virus sincitico respiratorio.
ATE229978T1 (de) Helicobacter proteine und impstoffe
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
AU3799789A (en) Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
NO870212L (no) Fremgangsmaate for fremstilling av stabile nikorandilpreparater.
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
NO911065L (no) Fremgangsmaate for fremstilling av lipopeptidderivater.
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
FR2748476B1 (fr) Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant
AU4450696A (en) Enhanced immunogenic vaccine
FR2715304B1 (fr) Vaccin anti-allergique.
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
RU96116250A (ru) Штамм pestivirus, используемый для изготовления лапинизированной вирус вакцины против классической чумы свиней
FI873483A7 (fi) Oksiraanipseudo-oligosakkarideja, menetelmä niiden valmistamiseksi, niiden käyttö ja farmaseuttisia valmisteita.
NO901892D0 (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
IT8919110A0 (it) Peptidi sintetici e loro uso come carriers universali per la preparazione di coniugati immunogenici adatti per lo sviluppo di vaccini sintetici.
FR2698271B1 (fr) Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination.
NO884921D0 (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
DK98788A (da) Benzylaminoaryl-dihydropyridinlactoner, fremgangmsaade til deres fremstilling samt deres anvendelse som laegemidler
ITRM920074A0 (it) Procedimento per la preparazione di vaccini, e vaccini cosi' ottenibili.
IT8884903A0 (it) Catetere per uso medicale.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0792165

Country of ref document: EP

REN Ceased due to non-payment of the annual fee